Myovant Sciences Ltd. at its 2022 Annual General Meeting of Shareholders held on October 21, 2022, approved the appointment of Shigeyuki Nishinaka as a director for a one-year term.
Myovant Sciences Ltd.
Equities
MYOV
BMG637AM1024
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+23.13% | 46.93B | |
+37.49% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |